Last update 03 Nov 2024
TQA-3605
Last update 03 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms TQA 3605, TQA-3605, TQA3605 |
Target |
Mechanism HBV capsid inhibitors(HBV capsid inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with TQA-3605A Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treated Subjects With Chronic HBV Infection With Low-level Viremia (LLV)
Randomized, Double-blind, Placebo-controlled Phase Ib/IIa Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment-naïve Patients and Treated Patients With Chronic Hepatitis B
评估TQA3605单药或联合核苷（酸）类似物在初治及经治慢性乙型肝炎患者中的有效性和安全性的随机、双盲、安慰剂对照的Ib/IIa期临床试验
[Translation] A randomized, double-blind, placebo-controlled Phase Ib/IIa clinical trial to evaluate the efficacy and safety of TQA3605 alone or in combination with nucleoside (acid) analogs in patients with treatment-naive and treatment-experienced chronic hepatitis B
100 Clinical Results associated with TQA-3605
Login to view more data
100 Translational Medicine associated with TQA-3605
Login to view more data
100 Patents (Medical) associated with TQA-3605
Login to view more data
100 Deals associated with TQA-3605
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Viremia | Phase 2 | CN | 01 Nov 2024 | |
| Hepatitis B, Chronic | Phase 2 | CN | 17 Oct 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free